DF
HAE icon

DecisionPoint Financial’s Haemonetics HAE Stock Holding History

DecisionPoint Financial’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75 Buy
+1
New +$64 ﹤0.01% 1273

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DecisionPoint Financial's HAE Position: Q2 2026 in Review

DecisionPoint Financial opened a new position in Haemonetics (HAE) in Q2 2026: 1 share worth $75. The stake represents ﹤0.01% of the portfolio and ranks #1273 among its holdings.

329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • DecisionPoint Financial held 1 share of Haemonetics worth $75 as of Q2 2026.
  • Haemonetics was a new DecisionPoint Financial position in Q2 2026.
  • Haemonetics made up ﹤0.01% of DecisionPoint Financial's portfolio in Q2 2026, its #1273 holding.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on DecisionPoint Financial's 13F filing for Q2 2026, filed 5 Aug 2026.